User contributions for KatC
Jump to navigation
Jump to search
11 July 2020
- 18:5918:59, 11 July 2020 diff hist +967 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name No edit summary current
- 18:3518:35, 11 July 2020 diff hist +3 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Secondary Outcomes
- 18:3018:30, 11 July 2020 diff hist −2 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Primary Outcomes
- 18:3018:30, 11 July 2020 diff hist +26 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Adverse Events
- 18:2818:28, 11 July 2020 diff hist +675 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Major Points
- 18:0718:07, 11 July 2020 diff hist +402 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Criticisms
- 17:3117:31, 11 July 2020 diff hist 0 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Design
- 17:1917:19, 11 July 2020 diff hist +70 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name No edit summary
- 17:0417:04, 11 July 2020 diff hist +297 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Further Reading
- 16:5916:59, 11 July 2020 diff hist +42 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Funding
- 16:5716:57, 11 July 2020 diff hist −7 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Design
- 16:5516:55, 11 July 2020 diff hist 0 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Outcomes
- 16:5416:54, 11 July 2020 diff hist +261 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Adverse Events
- 16:5116:51, 11 July 2020 diff hist −104 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Secondary Outcomes
- 16:5016:50, 11 July 2020 diff hist +470 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Secondary Outcomes
- 16:3616:36, 11 July 2020 diff hist −1,204 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Primary Outcomes
- 16:3516:35, 11 July 2020 diff hist +1,260 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Outcomes
- 16:2416:24, 11 July 2020 diff hist −5 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name →Interventions
- 16:2316:23, 11 July 2020 diff hist +406 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name No edit summary
- 16:1416:14, 11 July 2020 diff hist +556 Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name No edit summary
- 15:4015:40, 11 July 2020 diff hist +6,184 N Efficacy and Safety of Belimumab in Patients With Active Systemic Lupus Erythematosus: A Randomised, Placebo-Controlled, Phase 3 Trial, placebo-controlled, phase 3 trialrticle name Created page with "==Clinical Question== <!-- This should be a PICO (Population, Intervention, Comparison, Outcome) style question. As an example, the ACCORD trial's clinical question is shown b..."